Bio-Thera Kicks Off Phase III Trial For Stelara Rival

Chinese Biosimilars Developer Begins Study For BAT2206 Ustekinumab Candidate

 
• By David Wallace
Clinical Trial
Bio-Thera has begun Phase III trials for ustekinumab • Source: Shutterstock

More from Biosimilars

More from Products